Lanean...
Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence
The introduction of liver transplant listing criteria for hepatocellular cancer (HCC) has significantly improved oncological outcomes and survival. But despite this HCC recurrence is still problematic. There is emerging evidence that the choice of immunosuppression (IS) after transplant for HCC can...
Gorde:
| Argitaratua izan da: | Transl Gastroenterol Hepatol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5244705/ https://ncbi.nlm.nih.gov/pubmed/28138592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2016.03.18 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|